Diagnostic Imaging Devices are used for the visualization of structural and functional patterns of organs or tissues. Contrast media injectors are devices used to inject contrast media agents into the bloodstream of patients to enable the visualization of various pathologies through X-ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), or other medical imaging devices. GlobalData uses proprietary data and analytics to provide a comprehensive report on the contrast media injectors devices market, including market shares of different players within Norway. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the contrast media injectors market in Norway was Imaxeon followed by Guerbet, Bracco Imaging and ulrich.
CT Injectors, MRI Injectors and Angiographic Injectors have been included in this category. CT Injectors are devices used in conjunction with CT systems to inject contrast media agents into the blood stream of patients. MRI Injectors are devices used in conjunction with MRI systems to inject contrast media agents into the blood stream of patients. Angiographic Injectors are devices used during cardiac and vascular angiographic interventions to inject contrast media agents into the blood stream of patients.
The value of the contrast media injectors devices market within Norway was expected to be over $2m in 2023.
For the latest complete market share analysis of contrast media injectors device market in Norway, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
